Is Marvel Biosciences Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Marvel Biosciences Corp (MRVL.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Marvel Biosciences Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Marvel Biosciences Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Marvel Biosciences Corp?

Muslim investors may consider investing in Marvel Biosciences Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Marvel Biosciences Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Marvel Biosciences Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Marvel Biosciences Corp updated?

The Shariah compliance status of Marvel Biosciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Marvel Biosciences Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Marvel Biosciences Corp?

You can check the latest Shariah compliance status of Marvel Biosciences Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MRVL.V Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 14, 2025

Report Source: 2025 3rd Quarter Report

Marvel Biosciences Corp. Stock Analysis MRVL.V

Canada N/A Nano Cap Report: Q3, 2025

Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Key Statistics of Marvel Biosciences Corp (MRVL.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.16CAD0.17

Today's Open

CAD0.17

Volume

32.50K

P/E Ratio (TTM)

52 Week Range

CAD0.08CAD0.40

Market Cap

7.83M

Avg. Volume

56.13K

Dividend Yield

Financial Metrics & Statements of Marvel Biosciences Corp (MRVL.V)

FAQ's for Marvel Biosciences Corp (MRVL.V)

According to Musaffa’s Shariah screening methodology, Marvel Biosciences Corp (MRVL.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.